4//SEC Filing
Baltic Charles V. III 4
Accession 0000899243-22-025740
CIK 0001262104other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 6:01 PM ET
Size
14.0 KB
Accession
0000899243-22-025740
Insider Transaction Report
Form 4
MEI Pharma, Inc.MEIP
Baltic Charles V. III
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-07-05+87,500→ 87,500 totalExercise: $0.54Exp: 2032-07-05→ Common Stock (87,500 underlying)
Holdings
- 50,000
Stock Option (Right to Buy)
Exercise: $2.95Exp: 2031-07-01→ Common Stock (50,000 underlying) - 40,000
Stock Option (Right to Buy)
Exercise: $1.36Exp: 2026-07-29→ Common Stock (40,000 underlying) - 40,000
Stock Option (Right to Buy)
Exercise: $2.83Exp: 2027-07-06→ Common Stock (40,000 underlying) - 40,000
Stock Option (Right to Buy)
Exercise: $2.52Exp: 2029-07-01→ Common Stock (40,000 underlying) - 20,000
Stock Option (Right to Buy)
Exercise: $1.57Exp: 2025-07-28→ Common Stock (20,000 underlying) - 50,000
Stock Option (Right to Buy)
Exercise: $3.49Exp: 2030-07-02→ Common Stock (50,000 underlying) - 40,000
Stock Option (Right to Buy)
Exercise: $4.28Exp: 2028-07-12→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]The options will vest in equal monthly installments over twelve months.
- [F2]All of such options are presently exercisable.
Documents
Issuer
MEI Pharma, Inc.
CIK 0001262104
Entity typeother
Related Parties
1- filerCIK 0001533340
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 6:01 PM ET
- Size
- 14.0 KB